Clostridium difficile Infections Pipeline Analysis Demonstrates 18+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
03 mai 2023 13h00 HE
|
DelveInsight Business Research LLP
New York, USA, May 03, 2023 (GLOBE NEWSWIRE) -- Clostridium difficile Infections Pipeline Analysis Demonstrates 18+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...
Vitality Biopharma Discovers and Patents Use of Cannabinoids for C.diff-Associated Diarrhea and Colitis
10 mai 2018 08h30 HE
|
Vitality Biopharma, Inc
- Vitality’s GI-targeted VBX-100 THC compound to be investigated as treatment of recurrent C. difficile infections LOS ANGELES, May 10, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc....